Condition: Non Small Cell Lung Cancer · Epidermal Growth Factor Receptor Gene Mutation · Stage III Lung Cancer · Sponsor: PrECOG, LLC.
The goal of the study is to collect data on patients treated outside of a clinical trial (in routine clinical practice) with standard of care osimertinib with or without chemotherapy in Epidermal Growth Factor Receptor (EGFR)-mutant Non-Small Cell Lung Cancer (NSCLC) to better understand the safety and effectiveness of these standard of care regimens.
This description comes directly from the study's public registry record.
Karen Fitzpatrick, RN · 215-439-2294 · PrE1702@precogllc.org
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham | Birmingham, Alabama, United States | Recruiting |
| Mercy Clinic Fort Smith Communities | Fort Smith, Arkansas, United States | Recruiting |
| Mercy Research | Fort Smith, Arkansas, United States | Recruiting |
| Fowler Family Cancer Center - Jonesboro | Jonesboro, Arkansas, United States | Recruiting |
| Stanford Cancer Center Emeryville | Emeryville, California, United States | Recruiting |
| Stanford Cancer Institute Palo Alto | Palo Alto, California, United States | Recruiting |
| Stanford Cancer Center South Bay | San Jose, California, United States | Recruiting |
| John Muir Health | Walnut Creek, California, United States | Recruiting |
| Bayhealth | Dover, Delaware, United States | Recruiting |
| Satellite of Bayhealth Sussex | Milford, Delaware, United States | Recruiting |
| Sibley Johns Hopkins University | Washington D.C., District of Columbia, United States | Recruiting |
| Lewis Cancer and Research Pavilion at Saint Joseph's/Candler: Liberty County Cancer Care | Hinesville, Georgia, United States | Recruiting |
+ 134 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06538038